Using AI to identify lymph node metastasis in gastric cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on developing an artificial intelligence-driven model to accurately identify lymph node metastasis in patients with gastric cancer. A multidisciplinary team, including oncologists, radiologists, and data scientists, will collaborate to create this model. Participants will undergo standard diagnostic procedures, and the AI model will analyze imaging and pathological data to predict lymph node involvement. The study aims to validate the AI model's accuracy by comparing its predictions with traditional diagnostic methods.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Diagnosis of Gastric Cancer: Confirmed diagnosis of gastric cancer, either newly diagnosed or recurrent.
2. Lymph Node Involvement: Suspected or confirmed involvement of lymph nodes, as indicated by imaging studies or pathology reports.
3. Age: Patients aged 18 years or older.
4. Performance Status: An Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2, indicating a functional status that allows participation in the study.
5. Informed Consent: Ability to provide written informed consent to participate in the study.

Exclusion Criteria:

1. Pregnancy or Lactation: Pregnant or lactating women, due to potential risks to the fetus or infant.
2. Severe Comorbid Conditions: Presence of severe comorbid medical conditions that could interfere with the study or pose additional risks.
3. Previous AI-Driven Diagnostic Intervention: Prior use of any AI-driven diagnostic models specifically for gastric cancer lymph node metastasis.
4. Inability to Comply: Inability or unwillingness to comply with study procedures, including follow-up visits and data collection.
5. Mental or Cognitive Impairment: Conditions that impair the ability to provide informed consent or participate effectively in the study.

Where it's running

• Department of General Surgery
  Shijiazhuang, Hebei, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered tumor response assessment after preoperative treatment in stomach and gastroesophageal junction cancer

  Researchers are testing whether an AI tool called DeepTRG can reliably measure how much cancer remains in tissue removed after preoperative therapy in stomach and GEJ cancer, without needing a human to correct the AI results.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07849608

• AI-based prediction of who will respond to pre-surgery immunotherapy in locally advanced gastric cancer

  A real-world study will test whether an AI system can predict which patients with locally advanced gastric cancer will respond to neoadjuvant chemotherapy plus PD-1 inhibitors before surgery.

  Recruiting at 9 sites Hebei Medical University · Fuyang, Anhui and 8 other locations · NCT07401199

• DeepComp: AI prediction of complications after stomach cancer surgery

  This project will try an AI tool called DeepComp to predict which adults with gastric adenocarcinoma scheduled for curative stomach surgery are at high risk of moderate-to-severe postoperative complications using routine preoperative CT scans and clinical data.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07401173

• AI tool to predict lymph node spread and support doctors' decisions in early (T1) stomach cancer

  This study will test whether an AI that combines clinical information, pathology slides, and CT scans can predict lymph node spread in adults with T1 gastric cancer and help doctors of different experience levels make better treatment decisions.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07124754

• Creating a collaborative database for gastric cancer using AI technology

  This study is trying to create a shared database using AI to help doctors and researchers in Hebei Province better understand and treat gastric cancer by combining patient data from different hospitals.

  Recruiting Hebei Medical University · Shijiazhuang, Hebei · NCT06506825

• Understanding brain changes in patients with neurotoxicity from CAR T-cell therapy

  This study is trying to understand how CAR T-cell therapy affects the brain in patients who develop neurotoxicity, by looking at brain scans and certain chemicals in their spinal fluid.

  Recruiting Hebei Medical University · Shijiazhuang, Hebei · NCT05643092

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.